Lipoxygenase inhibiting activity of some Malaysian plants

Pharmaceutical Biology

Volumn 47, Issue 12, 2009, Pages 1142-1148

  Chung, Lip Yong ^a   Soo, Wei Kwan ^a   Chan, Kit Yee ^a   Mustafa, Mohd Rais ^a   Goh, Swee Hock ^b   Imiyabir, Zamrie ^c  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b FOREST RESEARCH INSTITUTE MALAYSIA   (Malaysia)

^c FOREST RESEARCH CENTRE   (Malaysia)

Author keywords

Anti inflammatory; FOX assay; Inflammation; Lipoxygenase; Malaysian plants

Indexed keywords

FERRIC OXIDE; LINOLEIC ACID; LIPOXYGENASE; PLANT EXTRACT; UNCLASSIFIED DRUG; XYLENE; XYLENOL ORANGE;

AGELAEA BORNEESIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BARK; BIOASSAY; CHISOCHETON POLYANDRUS; CONNARACEAE; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME INHIBITION; GARCINIA; GARCINIA CUSPIDATA; GUTTIFERAE; HIGH THROUGHPUT SCREENING; IC 50; MALAYSIA; MEDICINAL PLANT; MELIACEAE; NONHUMAN; OXIDATION; PLANT COMMUNITY; PLANT LEAF; RUBIACEAE; TIMONIUS FLAVESCENS;

AGELAEA; CHISOCHETON; CLUSIACEAE; CONNARACEAE; CUSPIDATA; GARCINIA; MELIACEAE; RUBIACEAE; TIMONIUS FLAVESCENS;

EID: 70450245368     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880200903008724     Document Type: Article

References (69)

1. Avis I, Hong SH, Martinez A, Moody T, Choi YH, Trepel J, Das R, Jett M, Mulsine JL (2001): Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J 15: 2007-2009.
2. Axelrod B, Cheesbrough TM, Laakso S (1981): LOX from soybeans. Methods Enzymol 71: 441-451.
3. Backlund MG, Mann JR, Dubois RN (2005): Mechanisms for the prevention of gastrointestinal cancer: The role of prostaglandin E2. Oncology 69: S28-32.
4. Bordoloi M, Saikia B, Mathur RK, Goswami BN (1993): A meliacin from Chisocheton paniculatus. Phytochemistry 34: 583-584.
5. Boyington JC, Gaffney BJ, Amzel LM (1993): The three-dimensional structure of an arachidonic acid 15-lipoxygenase. Science 260: 1482-1486.
6. Burdan F, Szumilo J, Klepacz R, Dudka J, Korobowicz A, Tokarska E, Cendrowska-Pinkosz M, Madej B, Klepacz L (2004): Gastrointestinal and hepatic toxicity of selective and nonselective cyclooxygenase-2 inhibitors in pregnant and non-pregnant rats. Pharmacol Res 50: 533-543.
7. Celotti F, Laufer S (2001): Anti-inflammatory drugs: New multitarget compounds to face an old problem. The dual inhibition concept. Pharmacol Res 43: 429-436.
8. Chatterjee A, Nayak L, Das B, Putra A, Dhara KP, Mukherjee K, Banerji J, Shoolery JN (1989): Chemistry of phytoconstituents of Chisocheton paniculatus Hiern (Meliaceae). Indian J Chem, Sect B: Org Chem Incl Med Chem 28: B231-236.
9. Chen M, Lam BK, Kanaoka Y, Nigrovic PA, Audoly LP, Austen KF, Lee DM (2006): Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. J Exp Med 203: 837-842.
10. Chomnawang MT, Surassmo S, Nukoolkarn VS, Gritsanapan W (2007): Effect of Garcinia mangostana on inflammation caused by Propionibacterium acnes. Fitoterapia 78: 401-408.
11. Chung PY, Chung LY, Ngeow YF, Goh SH, Imiyabir Z (2004): Antimicrobial activities of Malaysian plant species. Pharm Biol 42: 292-300.
12. Chung LY, Goh SH, Imiyabir Z (2005a): Central nervous system receptor activities of some Malaysian plant species. Pharm Biol 43: 280-288. (Pubitemid 40745456)
13. Chung LY, Goh SH, Majalap N (2006): Activity profiles of Malaysian plant species on some G-protein coupled receptors, in: Singh VK, Govil JN, Ahmad K, Sharma RKR, eds, Recent Progress in Medicinal Plants, Vol.15, Natural Products. Houston, TX, Studium Press, pp. 291-308.
14. Chung LY, Yap KF, Mustafa MR, Goh SH, Imiyabir Z (2005b): Muscarinic receptor activity of some Malaysian plant species. Pharm Biol 43: 672-682. (Pubitemid 43062363)
15. Chung LY, Yap KF, Goh SH, Mustafa MR, Imiyabir Z (2008): Muscarinic receptor binding activity of polyoxygenated flavones from Melicope subunifoliolata. Phytochemistry 69: 1548-1554.
16. Connolly JD, Labbe C, Rycroft DS, Taylor DAH (1979): Tetranotriterpenoids and related compounds. Part 22. New apotirucallol derivatives and tetranortriterpenoids from the wood and the seeds of Chisocheton paniculatus (Meliaceae). J Chem Soc, Perkin Trans 112: 2995-12964
17. Erdelmeier CAJ, Hauer H, Sticher O, Rali T (1994): 10-- Deoxysecogalioside: A new iridoid glycoside from Timonius timon. Planta Med 60: 484-485.
18. Ferreira SH (2002): Peripheral analgesic sites of action of anti- inflammatory drugs. Int J Clin Pract Suppl 128: 2-10.
19. Funk CD (2005): Leukotriene modifiers as potential therapeutics for cardiovascular disease. Nat Rev Drug Discovery 4: 664-672.
20. Ghosh J, Myers CE (1998): Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci USA 95: 13182-13187.
21. Gopalakrishnan C, Shankaranarayanan D, Kameswaran L, Nazimudeen SK (1980): Effect of mangostin, a xanthone from Garcinia mangostana Linn. in immunopathological and inflammatory reactions. Indian J Exp Biol 18: 843-846.
22. Gunning PJ, Jeffs LB, Isman MB, Towers GHN (1994): Two limonoids from Chisocheton microcarpus. Phytochemistry 36: 1245-1245
23. Hahn EL, Gamelli RL (2000): Prostaglandin E2 synthesis and metabolism in burn injury and trauma. J Trauma 49: 1147-1154.
24. Hidenori K, Kyoko M, Hideaki O, Ryoji K, Kazuo Y (2003): Tricin from a Malagasy connaraceous plant with potent antihistaminic activity. J Nat Prod 66: 1273-1275.
25. Hlasta DJ, Casey FB, Ferguson EW, Gangell SJ, Heimann MR, Jaeger EP, Kullnig RK, Gordon RJ (1991): 5-LOX inhibitors: The synthesis and structure-activity relationships of a series of 1-phenyl-3- -pyrazolidinones. J Med Chem 34:1560-1570.
26. Honda T, Segi-Nishida E, Miyachi Y, Narumiya S (2006): Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis. J Exp Med 203: 325-335.
27. Huang LS, Kim MR, Sok D-E (2006): Linoleoyl lysophosphatidylcholine is an efficient substrate for soybean lipoxygenase-1. Arch Biochem Biophys 455: 119-126.
28. Hudson N, Balsitis M, Everitt S, Hawkey CJ (1993): Enhanced gastric mucosal leukotriene B-4 synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 34: 742-747.
29. Inada A, Somekawa M, Murata H, Nakanishi T, Tokuda H, Nishino H, Iwashima A, Darnaedi D, Jurata J (1993): Phytochemical studies on meliaceous plants. VIII structures and inhibitory effects on Epstein-Barr virus activation of triterpernoids from leaves of Chisocheton macrophyllus King. Chem Pharm Bull (Tokyo) 41: 617-619.
30. Jiang ZY, Hunt JV, Wolff SP (1992): Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem 202: 384-389.
31. Johns SR, Lamberton JA (1970): Identification of a new alkaloid from Timonium kaniensis (Rubiaceae) as dihydrocupreine. Aust J Chem 23: 211-212.
32. Jupp J, Hillier K, Elliot DH, Fine DR, Bateman AC, Johnson PA, Cazaly AM, Penrose JF, Sampson AP (2007): Colonic expression of leukotriene-pathway enzymes in inflammatory bowel diseases. Inflamm Bowel Dis 13: 537-546.
33. Khan IA, Sticher O, Rali T (1993): New triterpenes from the leaves of Timonius timon. J Nat Prod 56: 2163-2165.
34. Kingston WP (1981): 15-LOX: A rapid, sensitive assay for lox inhibitors. Br J Pharmacol 74: 919-920.
35. Kuhn H, O'Donnell VB (2006): Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res 45: 334-356.
36. Levick SP, Loch DC, Taylor SM, Janicki JS (2007): Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation. J Immunol 178: 641-646.
37. Liu JH, Zschocke S, Reininger E, Bauer R (1998): Inhibitory effects of Angelica pubescens f. biserrata on 5-lipoxygenase and cyclooxygenase. Planta Med 64: 525-529.
38. Mabuchi T, Kojima H, Abe T, Takagi K, Sakurai M, Ohmiya Y, Uematsu S, Akira S, Watanabe K, Ito S (2004): Membrane-associated prostaglandin E synthase-1 is required for neuropathic pain. Neuroreport 15: 1395-1398.
39. Mahesha HG, Singh SA, Appu Rao AG (2007): Inhibition of lipoxygenase by soy isoflavones: Evidence of isoflavones as redox inhibitors. Arch Biochem Biophys 461: 176-185.
40. Martel-Pelletier J, Lajeunesse D, Reboul P, Pelletier J-P (2003): Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis 62: 501-509.
41. McMillan RM (2001): Leukotrienes in respiratory diseases. Paediatr Respir Rev 2: 238-244.
42. Mehrabian M, Allayee H (2003): 5-lipoxygenase and atherosclerosis. Curr Opin Lipidol 14: 447-457.
43. Natarajan R, Nadler JL (2004): Lipid inflammatory mediators in diabetic vascular disease. Arterioscler Thromb Vasc Biol 24: 1542-1548.
44. Naveau B (2005): Dual inhibition of cyclo-oxygenases and 5-lipoxygenase: A novel therapeutic approach to inflammation? Joint Bone Spine 72: 199-201. (Pubitemid 40591758)
45. Nickerson-Nutter CL, Medvedeff ED (1996): The effects of leukotriene synthesis inhibitors in models of acute and chronic inflammation. Arthritis Rheum 39: 515-521.
46. Patöka J (2003): Biologically active pentacyclic triterpenes and their current medicine signification. J Appl Biomed 1: 7-12.
47. Prigge ST, Boyington JC, Faig M, Doctor KS, Gaffney BJ, Amzel LM (1997): Structure and mechanism of lipoxygenases. Biochimie 79: 629-636.
48. Profita M, Sala A, Riccobono L, Pace E, Paterno A, Zarini S, Siena L, Mirabella A, Bonsignore G, Vignola AM (2000): 15(S)-HETE modulates LTB4 production and neutrophil chemotaxis in chronic bronchitis. Am J Physiol-Cell Physiol 279: C1249-C1258.
49. Rainsford KD (2007): Anti-inflammatory drugs in the 21st century. Subcell Biochem 42: 3-27.
50. Romano M, Catalano A, Nutini M, D'Urbano E, Crescenzi C, Claria J, Libner R, Davi G, Procopio A (2001): 5-Lipoxygenase regulates malignant mesothelial cell survival: Involvement of vascular endothelial growth factor. FASEB J 15: 2326-2336.
51. Roos G, Waiblinger J, Zschocke S, Liu JH, Klaiber I, Kraus W, Bauer R (1997): Isolation, identification and screening for COX-1- and 5-LO-inhibition of coumarins from Angelica archangelica. Pharm Pharmacol Lett 7: 157-160.
52. Saikia B, Kataky JCS, Marthur RK, Baruah JN (1978): New meliacins from the fruits of Chisocheton paniculatus Hiern. Indian J Chem, Sect B: Org Chem Incl Med Chem 16: B1042-1044.
53. Samuelsson B, Dahlén S-E, Lindgren J-Å, , Rouzer CA, Serhan CN (1987): Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science 237: 1171-1176.
54. Schmidt C, Kosche E, Baumeister B, Vetter H (1995): Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease. Eur J Gastroenterol Hepatol 7: 865-869.
55. Schneider I, Bucar F (2005): Lipoxygenase inhibitors from natural plant sources. Part 2: Medicinal plants with inhibitory activity on arachidonate 12-lipoxygenase, 15-lipoxygenase and leukotriene receptor antagonists. Phytother Res 19: 263-272. (Pubitemid 41098116)
56. Scholz D, Baumann K, Grassberger M, Wolff-Winiski B, Rihs G, Walter H, Meingassner JG (2004): Synthesis of dammarane-type triterpenoids with anti-inflammatory activity in vivo. Bioorg Med Chem Lett 14: 2983-2986.
57. Shankaranarayan D, Gopalakrishnan C, Kameswaran L (1979): Pharmacological profile of mangostin and its derivatives. Arch Int Pharmacodyn Ther 239: 257-269.
58. Södergren E, Nourooz-Zadeh J, Berglund L, Vessby B (1998): Re-evaluation of the ferrous oxidation in xylenol orange assay for the measurement of plasma lipid hydroperoxides. J Biochem Biophys Method 37: 137-146. (Pubitemid 28517930)
59. Subbaramaiah K, Yoshimatsu K, Scherl E, Das KM, Glazier KD, Golijanin D, Soslow RA, Tanabe T, Naraba H, Dannenberg AJ (2004): Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease. Evidence for involvement of the transcription factor E-1. J Biol Chem 279: 12647-12658.
60. Vickery M, Vickery B (1980): Coumarins and related compounds in members of the Connaraceae. Toxico Lett 5: 115-118.
61. Waslidge NB, Hayes DJ (1995): A colorimetric method for the determination of lipoxygenase activity suitable for use in high throughput assay format. Anal Biochem 231: 354-358.
62. Weng J-R, Lin CN, Tsao L-T, Wang J-P (2003a): Novel and anti-inflammatory constituents of Garcinia subelliptica. Chem-Eur J 9: 1958-1963.
63. Weng J-R, Lin C-N, Tsao L-T, Wang J-P (2003b): Terpenoids with a new skeleton and novel triterpenoids with anti-inflammatory effects from Garcinia subelliptica. Chem-Eur J 9: 5520-5527.
64. Weng J-R, Tsao L-T, Wang J-P, Wu R-R, Lin C-N (2004): Antiinflammatory phloroglucinols and terpenoids from Garcinia subelliptica. J Nat Prod 67: 1796-1799.
65. Yadav RD, Kataky JCS, Mathur RK (1999): New protolimonoids and limonoids: Part I Isolation, structure elucidation of new protolimonoids and limonoid from the root wood of Chisocheton paniculatus Hiern (meliaceae). Indian J Chem, Sect B: Org Chem Incl Med Chem 38(B): 1359-1363.
66. Yedgar S, Krimsky M, Cohen Y, Flower RJ (2007): Treatment of inflammatory diseases by selective eicosanoid inhibition: A doubleedged sword? Trends Pharmacol Sci 28: 459-464.
67. Zhang JH, Chung TDY, Oldenburg KR (1999): A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4: 67-73.
68. Zhang YY, Walker JL, Huang A, Keaney Jr, Clish CB, Serhan CN, Loscalzo J (2002): Expression of 5-lipoxygenase in pulmonary artery endothelial cells. Biochem J 361: 267-276. (Pubitemid 34174493)
69. Zijlstra FJ, van Dijk AP, Garrelds IM, Ouwendijk RJ, Wilson JH (1991): Species differences in the pattern of eicosanoids produced by inflamed and non-inflamed tissue. Agents Actions Special issue: C73-75.